Literature DB >> 33910856

Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Reinhard E Friedrich1, Jozef Zustin2,3, Andreas M Luebke4, Thorsten Rosenbaum5, Martin Gosau6, Christian Hagel7, Felix K Kohlrusch6, Ilse Wieland8, Martin Zenker8.   

Abstract

BACKGROUND/AIM: Neurofibromatosis type 1 (NF) is an autosomal dominant hereditary disease. The cardinal clinical findings include characteristic skeletal alterations. Difficulties in diagnosis and therapy can arise if an individual has further illnesses. CASE REPORT: This is a case report of a 16-year-old patient affected by NF1. She also suffered from Alagille syndrome and the consequences of fetal alcohol exposure. The patient's facial phenotype showed findings that could be assigned to one or more of the known diseases. The patient was referred for treating a cherubism-like recurrent central giant cell granuloma (CGCG) of the jaw. The patient developed bilateral, multilocular non-ossifying fibromas (NOF) of the long bones of the lower extremity. Treatment of the skeletal lesions consisted of local curettage. While NOF regressed after surgery, the CGCG of the jaw remained largely unchanged. Extensive genetic tests confirmed a previously unknown germline mutation in the JAG1 gene, the germline mutation of the NF1 gene, and the somatic mutation in the NF1 gene in the diffuse plexiform neurofibroma, but not in the CGCG.
CONCLUSION: Assigning facial findings to a defined syndrome is ambiguous in many cases and especially difficult in patients who have multiple diseases that can affect the facial phenotype. Surgical therapy should be adapted to the individual findings. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Alagille syndrome; Jaffe-Campanacci syndrome; Neurofibromatosis type 1; central giant cell granuloma; central giant cell lesion; cherubism; non-ossifying fibroma; root resorption

Mesh:

Year:  2021        PMID: 33910856      PMCID: PMC8193341          DOI: 10.21873/invivo.12431

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  165 in total

1.  Multiple and large non-ossifying fibromas in children with neurofibromatosis.

Authors:  C Fauré; J M Laurent; P Schmit; D Sirinelli
Journal:  Ann Radiol (Paris)       Date:  1986

2.  Plexiform neurofibroma causing an ossifying subperiosteal haematoma: a rare case in the tibia of an 11-year-old girl.

Authors:  Anton Lavell; Christopher W Jones; Daniel Wong; Peter Counsel; Richard Carey-Smith
Journal:  Skeletal Radiol       Date:  2017-06-16       Impact factor: 2.199

Review 3.  Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next-generation sequencing.

Authors:  Carolina C Gomes; Marina G Diniz; Victor C Bastos; Vanessa F Bernardes; Ricardo S Gomez
Journal:  J Pathol       Date:  2019-12-18       Impact factor: 7.996

Review 4.  Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.

Authors:  Shivani Ahlawat; Jaishri O Blakeley; Shannon Langmead; Allan J Belzberg; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2019-08-08       Impact factor: 2.199

Review 5.  Health Supervision for Children With Neurofibromatosis Type 1.

Authors:  David T Miller; Debra Freedenberg; Elizabeth Schorry; Nicole J Ullrich; David Viskochil; Bruce R Korf
Journal:  Pediatrics       Date:  2019-05       Impact factor: 7.124

6.  Prosthodontic treatment and medical considerations for a patient with Turner syndrome: a clinical report.

Authors:  Caroline T Nguyen; Theresa M Hofstede
Journal:  J Prosthodont       Date:  2012-06-01       Impact factor: 2.752

7.  Analysis of orbital plain radiographs for orbital deformities in neurofibromatosis type 1 patients, with special reference to alterations of the orbital rim as indicators of adjacent plexiform neurofibroma.

Authors:  Reinhard E Friedrich; Jonathan Rother; Georg Christ; Marten Lehmann; Christine Gräfin Zu Eulenburg; Manfred Giese; Hanna A Scheuer
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

8.  Florid cemento-osseous dysplasia and peripheral giant cell granuloma in a patient with neurofibromatosis 1.

Authors:  Dmitry José de Santana Sarmento; Sérgio Henrique Gonçalves de Carvalho; José Cadmo Wanderley Peregrino de Araújo; Marianne de Vasconcelos Carvalho; Éricka Janine Dantas da Silveira
Journal:  An Bras Dermatol       Date:  2017 Mar-Apr       Impact factor: 1.896

Review 9.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

10.  Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.

Authors:  Silvia Vannelli; Raffaele Buganza; Federica Runfola; Ilaria Mussinatto; Antonio Andreacchio; Luisa de Sanctis
Journal:  Ital J Pediatr       Date:  2020-05-11       Impact factor: 2.638

View more
  1 in total

Review 1.  Giant Cell Lesions of the Jaws Involving RASopathy Syndromes.

Authors:  Melissa Luna; Nicholas Wolsefer; Carlos-Xavier Zambrano; Ivan James Stojanov
Journal:  Acta Stomatol Croat       Date:  2022-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.